Evidence map›Paper›PMID 42006509›Full record

ArticleEJIFCC2026

Hypophosphatasia with Coexisting Endocrinopathies: A Diagnostic Dilemma.

Anil K Chokkalla, Niyutchai Chaithongdi, Megan Bell

Abstract readCase Reports
In one paragraph

Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anil K ChokkallaLaboratory Medicine, Sanford Health, Fargo, ND, USA.
Niyutchai ChaithongdiEndocrinology, Sanford Health, Fargo, ND, USA.
Megan BellMedical Genetics, Sanford Health, Fargo, ND, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult-onset hypophosphatasia presents a diagnostic challenge due to confounding clinical and analytical factors. Although rare, the consequence of missed diagnosis is significant, as it can potentiate skeletal mineralization defects. Despite the recent development of diagnostic criteria, integration into routine clinical practice remains limited, partly due to the variable course of disease progression. Effective management often requires a multidisciplinary team, including rheumatologists, orthopedic surgeons, endocrinologists, medical geneticists, dentists, physical and occupational therapists, pain specialists and clinical biochemists. Here, we present a case of adult-onset autosomal dominant hypophosphatasia, where diagnosis was complicated by coexisting endocrine disorders, Addison's disease and primary hypothyroidism. Persistently decreased alkaline phosphatase activity had been observed for over a decade and were initially attributed to hypothyroidism. However, an endocrinologist's clinical suspicion led to genetic testing, confirming hypophosphatasia. Although the patient exhibited no additional symptoms such as premature tooth loss, osteopenia, or osteoporosis, this incidental finding prompted a referral to medical genetics, carrier screening to support family planning, and cascade testing for family members.

Indexed as

Alkaline PhosphataseHypophosphatasiaInborn Errors of MetabolismUrine Phosphoethanolamine

Identifiers

PMID42006509
PMCPMC13088442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.